China Pharma Holdings, Inc.
CPHI
$0.82
-$0.02-2.38%
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -3.58% | -19.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.58% | -19.78% | |||
| Cost of Revenue | 23.90% | -35.08% | |||
| Gross Profit | -70.72% | 89.32% | |||
| SG&A Expenses | 13.44% | 13.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.30% | -13.39% | |||
| Operating Income | -28.15% | 6.87% | |||
| Income Before Tax | -27.56% | 6.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -27.56% | 6.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -27.56% | 6.46% | |||
| EBIT | -28.15% | 6.87% | |||
| EBITDA | -141.40% | 80.54% | |||
| EPS Basic | 19.46% | 75.28% | |||
| Normalized Basic EPS | 19.35% | 75.31% | |||
| EPS Diluted | 19.46% | 75.28% | |||
| Normalized Diluted EPS | 19.35% | 75.31% | |||
| Average Basic Shares Outstanding | 58.28% | 278.67% | |||
| Average Diluted Shares Outstanding | 58.28% | 278.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||